Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA proposes adding suffixes to distinguish biosimilar drug names

Cheaper versions of biologic drugs would be identified by a suffix to distinguish them from their more expensive, branded counterparts under draft guidance issued on Thursday by the U.S. Food and Drug Administration. The FDA said its proposal is designed to prevent inadvertent substitution of non-interchangeable products and to make it easier to monitor and […]

Read More »

Survey shows: Americans like working out more than eating right

BOSTON, Aug. 27, 2015 /PRNewswire/ — Americans are doing a great job at the gym but a mediocre job at the dinner table. Even though science suggests diet is more important than exercise in fighting obesity, diet is losing, and losing badly, to exercise. That’s according to a new Brodeur Partners Health and Wellness survey finding […]

Read More »

2 Billion Dollar Verdict Sought In Actos Trial

LAS VEGAS, Aug. 27, 2015 /PRNewswire/ — The nation’s newest Actos trial gets underway Thursday, August 27th in a Las Vegas courtroom.  Attorneys representing two southern Nevada patients will argue the men suffered severe effects, including death, after using the diabetes drug Actos. “Takeda Pharmaceuticals withheld from our clients what they as a company knew, […]

Read More »

U.S. FDA approves Synjardy (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 27, 2015 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Synjardy® (empagliflozin and metformin hydrochloride) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY), for the treatment of adults with type 2 diabetes (T2D). SYNJARDY is the third product containing empagliflozin to […]

Read More »

FTC May Require Products Worth $600 Million to be Divested for Teva-Allergan Deal to Go Through

MUMBAI: As Israeli drugmaker Teva readies to acquire Allergan as part of its recent $40.5-billion deal, a large bounty of products is expected to be up for grabs for generic drugmakers. According to collated data, products worth nearly $600 million may be needed to be divested as part of the anti-trust regulations of the US […]

Read More »

Firstborn Women More Likely To Be Obese, Journal Of Epidemiology & Community Health Reveals

Firstborn Women More Likely To Be Overweight/Obese As Adults Than Second-Born Sisters Study backs up research on male firstborns; shrinking family size may be contributing to observed rise in adult weight   Firstborn women are more likely to be overweight/obese as adults than their second-born sisters, finds the largest study of its kind in women, […]

Read More »

Global life expectancy rises, but people live sicker for longer

People around the world are living longer, but many are also living sicker lives for longer, according to a study of all major diseases and injuries in 188 countries.   General health has improved worldwide, thanks to significant progress against infectious diseases such as HIV/AIDS and malaria in the past decade and gains in fighting […]

Read More »

FDA wants food companies to hand over their pathogens

Investigations into foodborne illness are being radically transformed by whole genome sequencing, which federal officials say is enabling them to identify the source of an outbreak far more quickly and prevent additional cases.   Previously, samples from sick patients were sent to state and federal labs, where disease detectives ran tests to see if the […]

Read More »

Novo Nordisk A/S to Invest $1.2 to $1.7 Billion in North Carolina and Create 700 Jobs

Copenhagen, Denmark-based Novo Nordisk (NVO) and the governor of North Carolina, Pat McCrory, announced today that the company will spend between $1.2 and $1.7 billion to build a new manufacturing facility in Johnston County, N.C.   The new manufacturing plant is expected to create approximately 700 jobs over the next five years. It will manufacture […]

Read More »

Surgeon performance unaffected by fatigue from overnight work: study

Going without sleep the night before does not affect the performance of doctors doing elective surgery the next morning, according to a new Ontario study that runs contrary to research demonstrating that sleep-deprived physicians pose a hazard to patients. The odds of having a surgery-related problem were 22.2 percent when the doctor had been treating […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom